ID: ALA4159492

Max Phase: Preclinical

Molecular Formula: C21H23BrN2O6

Molecular Weight: 479.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCOC(=O)C1=C(C)NC2=C(C(=O)C(C)(C)CC2)C1c1cc(Br)cc([N+](=O)[O-])c1O

Standard InChI:  InChI=1S/C21H23BrN2O6/c1-5-30-20(27)15-10(2)23-13-6-7-21(3,4)19(26)17(13)16(15)12-8-11(22)9-14(18(12)25)24(28)29/h8-9,16,23,25H,5-7H2,1-4H3

Standard InChI Key:  YMDMHKSJWIWQSV-UHFFFAOYSA-N

Associated Targets(Human)

Voltage-gated T-type calcium channel alpha-1H subunit 1913 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Voltage-gated L-type calcium channel alpha-1C subunit 1321 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 479.33Molecular Weight (Monoisotopic): 478.0739AlogP: 4.23#Rotatable Bonds: 4
Polar Surface Area: 118.77Molecular Species: ACIDHBA: 7HBD: 2
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.08CX Basic pKa: CX LogP: 4.00CX LogD: 2.74
Aromatic Rings: 1Heavy Atoms: 30QED Weighted: 0.38Np Likeness Score: -0.48

References

1. Schaller D, Gündüz MG, Zhang FX, Zamponi GW, Wolber G..  (2018)  Binding mechanism investigations guiding the synthesis of novel condensed 1,4-dihydropyridine derivatives with L-/T-type calcium channel blocking activity.,  155  [PMID:29843108] [10.1016/j.ejmech.2018.05.032]

Source